Orchard Therapeutics to Webcast Conference Call of First Quarter 2019 Financial Results on May 28, 2019
A live webcast will be available under "News & Events" in the Investors & Media section of the company's website at orchard-tx.com. The conference call can be accessed by dialing 1-866-930-5155 (U.S. domestic) or +1-409-937-8974 (international) and referring to conference ID 2764629. A replay of the webcast will be archived on the Orchard website following the presentation.
Orchard’s portfolio of autologous, ex vivo, hematopoietic stem cell gene therapies includes Strimvelis, a gammaretroviral vector based gene therapy and the first such treatment approved by the
Orchard currently has offices in the
Director, Investor Relations
Source: Orchard Therapeutics plc